Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 50 results in range #1,001 to #1,050.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Calvin Ridley 66 Yd pass from Jalen Hurts (JK Scott Kick) (11/18/17)
  2. Calvin Ridley 7 Yd pass from Tua Tagovailoa (Andy Pappanastos Kick) (1/8/18)
  3. Calvin Ridley run for 13 yds to the FrsSt 5 for a 1ST down (9/9/17)
  4. Calvin Ridley run for 4 yds to the Vandy 29 (9/23/17)
  5. Cam Akers run for 1 yd to the FlaSt 42 (9/2/17)
  6. Cam Akers run for 3 yds to the FlaSt 10 (9/2/17)
  7. Cam Akers run for 4 yds to the Alab 45 (9/2/17)
  8. Cam Akers run for 6 yds to the FlaSt 16 (9/2/17)
  9. Cam Akers run for 6 yds to the FlaSt 22 for a 1ST down (9/2/17)
  10. Cam Akers run for 7 yds to the FlaSt 41 for a 1ST down (9/2/17)
  11. Cam Akers run for 9 yds to the FlaSt 34 (9/2/17)
  12. Cam Akers run for a loss of 1 yard to the FlaSt 24 (9/2/17)
  13. Cam Akers run for a loss of 2 yards to the FlaSt 4 (9/2/17)
  14. Cam Akers run for a loss of 3 yards to the Alab 38 (9/2/17)
  15. Cam Sims 8 Yd pass from Tua Tagovailoa (JK Scott Kick) (11/18/17)
  16. Cameron Gamble kickoff for 57 yds Henry Ruggs III return for 18 yds to the Alab 26 (11/4/17)
  17. Cameron Gamble kickoff for 65 yds for a touchback (11/4/17a)
  18. Cameron Gamble kickoff for 65 yds for a touchback (11/4/17b)
  19. Cameron Nizialek punt for 39 yds Trevon Diggs returns for 2 yds to the Alab 35 ALABAMA Penalty Offensive Holding (Derek Kief) to the Alab 25 (1/8/18)
  20. Cameron Nizialek punt for 41 yds Trevon Diggs returns for 14 yds to the Alab 44 (1/8/18)
  21. Cameron Nizialek punt for 45 yds Trevon Diggs returns for no gain to the Alab 17 (1/8/18)
  22. Cameron Nizialek punt for 49 yds fair catch by Trevon Diggs at the Alab 20 (1/8/18)
  23. Cameron Nizialek punt for 51 yds Trevon Diggs returns for 14 yds to the Alab 35 (1/8/18)
  24. Cameron Nizialek punt for 51 yds Trevon Diggs returns for 8 yds to the Alab 34 (1/8/18)
  25. Campbell VT, et al. Mol. Cancer Ther. (2014) cited as Ref 227 in DOI: 10.1038/s41392-020-0110-5
  26. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals (DOI: 10.1080/09273948.2020.1738501)
  27. Cao B, et al, N Engl J Med (2020), cited as Ref 11 in DOI: 10.1016/j.clim.2020.108427
  28. Cao B, et al, N Engl J Med (2020), cited as Ref 81 in DOI:10.1007/s11886-020-01292-3
  29. Cao Z, et al, Virol J (2010), cited as Ref 50 in DOI:10.1007/s11886-020-01292-3
  30. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
  31. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2)
  32. Caridi-Scheible M, et al, COVID-19 Clinical Rounds (2019), cited as Ref 40 in DOI: 10.1186/s13054-020-02882-x
  33. Carmon KS, et al. Proc. Natl Acad. Sci. USA (2011) cited as Ref 172 in DOI: 10.1038/s41392-020-0110-5
  34. Carnero A, et al. Cancer Treat. Rev. (2016) cited as Ref 508 in DOI: 10.1038/s41392-020-0110-5
  35. Cartwright P, et al. Development (2005) cited as Ref 114 in DOI: 10.1038/s41392-020-0110-5
  36. Casazza A, et al. Oncogene (2014) cited as Ref 516 in DOI: 10.1038/s41392-020-0110-5
  37. Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5
  38. Castrignano SB, et al, Virus Res. (2013), cited as Ref 20 in DOI: 10.3390/v12020211
  39. Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5
  40. Cauchemez S (3rd author of DOI /10.3201/eid2605.200146)
  41. Cavarretta IT, et al. Mol. Ther. (2010) cited as Ref 493 in DOI: 10.1038/s41392-020-0110-5
  42. Center for Disease Control and Prevention, Journal (2020), cited as Ref 22 in DOI: 10.1016/j.clim.2020.108427
  43. Centers for Disease Control and Prevention, et al, (2020), cited as Ref 54 in DOI: 10.1016/j.jcv.2020.104372
  44. Cerwenka A, et al, J Exp Med (1999), cited as Ref 36 in DOI:10.1007/s11886-020-01292-3
  45. Cerwenka A, et al, J Immunol (1999), cited as Ref 35 in DOI:10.1007/s11886-020-01292-3
  46. Chaffer CL, et al. Cell (2013) cited as Ref 484 in DOI: 10.1038/s41392-020-0110-5
  47. Chaffer CL, et al. Science (2011) cited as Ref 26 in DOI: 10.1038/s41392-020-0110-5
  48. Chai S, et al. Hepatology (2016) cited as Ref 156 in DOI: 10.1038/s41392-020-0110-5
  49. Chambers I, et al. Cell (2003) cited as Ref 86 in DOI: 10.1038/s41392-020-0110-5
  50. Chambers I, et al. Cloning Stem Cells (2004) cited as Ref 327 in DOI: 10.1038/s41392-020-0110-5

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)